Evidence for alpha-synuclein aggregation in older individuals with hyposmia: a cross-sectional studyResearch in context
Summary: Background: Synuclein pathology in neurodegenerative diseases, such as Parkinson’s disease (PD) and Dementia with Lewy bodies (DLB), begins years before motor or cognitive symptoms arise. Alpha-Synuclein seed amplification assays (α-syn SAA) may detect aggregated synuclein before symptoms...
Saved in:
Main Authors: | Kenneth Marek, David S. Russell, Luis Concha-Marambio, Seung Ho Choi, Danna Jennings, Michael C. Brumm, Christopher S. Coffey, Ethan Brown, John Seibyl, Matthew Stern, Claudio Soto, Andrew Siderowf |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396425000118 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Alpha synuclein and inflammaging
by: Geneviève L. Putnam, et al.
Published: (2025-01-01) -
Magnetic susceptibility components reveal different aspects of neurodegeneration in alpha-synucleinopathies
by: Oliver C. Kiersnowski, et al.
Published: (2025-02-01) -
Astaxanthin-loaded brain-permeable liposomes for Parkinson’s disease treatment via antioxidant and anti-inflammatory responses
by: Thai-Duong Nguyen, et al.
Published: (2025-02-01) -
Individualized brain radiomics-based network tracks distinct subtypes and abnormal patterns in prodromal Parkinson's disease
by: Lin Hua, et al.
Published: (2025-02-01) -
Alpha synuclein overexpression can drive microbiome dysbiosis in mice
by: Timothy R. Sampson, et al.
Published: (2025-02-01)